Vivos Therapeutics (VVOS) FCF Margin Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -80.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 473.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 23.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -431.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1,716.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,811.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2,833.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 192.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 261.00 |
| 10 | Vivos Therapeutics | 9.87 Mn | 7.64 Mn | 3.06 Mn | 1,265.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,265.00 |
| Dec 31, 2025 | -5,556.00 |
| Sep 30, 2025 | 5,309.00 |
| Jun 30, 2025 | -3,396.00 |
| Mar 31, 2025 | -5,237.00 |
| Dec 31, 2024 | 25.00 |
| Sep 30, 2024 | -2,890.00 |
| Jun 30, 2024 | 626.00 |
| Mar 31, 2024 | 1,551.00 |
| Dec 31, 2023 | -212.00 |
| Sep 30, 2023 | 5,643.00 |
| Jun 30, 2023 | 3,778.00 |
| Mar 31, 2023 | 7,764.00 |
| Dec 31, 2022 | -3,053.00 |
| Sep 30, 2022 | -4,234.00 |
| Jun 30, 2022 | -1,156.00 |
| Mar 31, 2022 | -4,998.00 |
| Dec 31, 2021 | 5,885.00 |
| Sep 30, 2021 | -7,811.00 |
| Jun 30, 2021 | -8,113.00 |
| Mar 31, 2021 | -10,688.00 |